Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...
SEER 1975–2023 analysis demonstrated a long-term mortality inflection from rising rates to sustained declines, with the ...
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results